These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 8533023

  • 1. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M, Matovu E, Brun R, Kaminsky R.
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [Abstract] [Full Text] [Related]

  • 2. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
    Matovu E, Enyaru JC, Legros D, Schmid C, Seebeck T, Kaminsky R.
    Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
    [Abstract] [Full Text] [Related]

  • 3. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
    Kibona SN, Matemba L, Kaboya JS, Lubega GW.
    Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T, Yang S, Braissant O, Boykin DW, Brun R, Wang MZ.
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.
    Bacchi CJ, Nathan HC, Yarlett N, Goldberg B, McCann PP, Sjoerdsma A, Saric M, Clarkson AB.
    Antimicrob Agents Chemother; 1994 Mar; 38(3):563-9. PubMed ID: 8203855
    [Abstract] [Full Text] [Related]

  • 9. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R, Schumacher R, Schmid C, Kunz C, Burri C.
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model.
    Ndung'u K, Murilla GA, Thuita JK, Ngae GN, Auma JE, Gitonga PK, Thungu DK, Kurgat RK, Chemuliti JK, Mdachi RE.
    PLoS One; 2020 Nov; 15(11):e0229060. PubMed ID: 33151938
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E, Kaminsky R.
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Veterinary link to drug resistance in human African trypanosomiasis?
    Barrett MP.
    Lancet; 2001 Aug 25; 358(9282):603-4. PubMed ID: 11530144
    [No Abstract] [Full Text] [Related]

  • 16. Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense isolated from sleeping sickness patients.
    Kagira JM, Maina N.
    Onderstepoort J Vet Res; 2007 Mar 25; 74(1):17-22. PubMed ID: 17708149
    [Abstract] [Full Text] [Related]

  • 17. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N, Maina KJ, Mäser P, Brun R.
    Acta Trop; 2007 Mar 25; 104(2-3):84-90. PubMed ID: 17765860
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from West and Central Africa isolated in the periods 1960-1995 and 1999-2004.
    Likeufack AC, Brun R, Fomena A, Truc P.
    Acta Trop; 2006 Nov 25; 100(1-2):11-6. PubMed ID: 17078916
    [Abstract] [Full Text] [Related]

  • 19. Resistance to DL-alpha-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense. Role of S-adenosylmethionine.
    Bacchi CJ, Garofalo J, Ciminelli M, Rattendi D, Goldberg B, McCann PP, Yarlett N.
    Biochem Pharmacol; 1993 Aug 03; 46(3):471-81. PubMed ID: 8347171
    [Abstract] [Full Text] [Related]

  • 20. Response of a T. b. rhodesiense stock with reduced drug susceptibility in vitro to treatment in mice and cattle.
    Enyaru JC, Matovu E, Lubega GW, Kaminsky R.
    Acta Trop; 1998 Jun 03; 69(3):261-9. PubMed ID: 9638278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.